Oxbow Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$233K Buy
+201
New +$237K 0.02% 236
2025
Q3
– Sell
-727
Closed -$566K – 225
2025
Q2
$566K Sell
727
-218
-23% -$169K 0.06% 132
2025
Q1
$781K Hold
945
– – 0.08% 121
2024
Q4
$730K Sell
945
-147
-13% -$122K 0.09% 121
2024
Q3
$967K Buy
1,092
+46
+4% +$41.4K 0.1% 110
2024
Q2
$947K Buy
1,046
+25
+2% +$20K 0.11% 101
2024
Q1
$794K Sell
1,021
-243
-19% -$173K 0.11% 99
2023
Q4
$737K Buy
1,264
+1
+0.1% +$584 0.11% 104
2023
Q3
$679K Buy
1,263
+418
+49% +$215K 0.11% 101
2023
Q2
$396K Buy
845
+52
+7% +$21.8K 0.06% 144
2023
Q1
$272K Hold
793
– – 0.05% 172
2022
Q4
$290K Hold
793
– – 0.05% 168
2022
Q3
$256K Buy
+793
New +$251K 0.04% 206
2022
Q1
– Sell
-975
Closed -$269K – 275
2021
Q4
$269K Hold
975
– – 0.03% 243
2021
Q3
$225K Hold
975
– – 0.02% 260
2021
Q2
$224K Sell
975
-110
-10% -$22.1K 0.02% 266
2021
Q1
$203K Buy
+1,085
New +$212K 0.02% 270
2020
Q2
– Sell
-1,883
Closed -$261K – 282
2020
Q1
$261K Hold
1,883
– – 0.04% 226
2019
Q4
$248K Buy
+1,883
New +$218K 0.03% 252
2018
Q2
– Sell
-5,326
Closed -$412K – 305
2018
Q1
$412K Sell
5,326
-110
-2% -$8.86K 0.08% 168
2017
Q4
$459K Buy
5,436
+113
+2% +$9.6K 0.09% 174
2017
Q3
$455K Sell
5,323
-4,999
-48% -$410K 0.09% 163
2017
Q2
$850K Buy
+10,322
New +$842K 0.15% 140

Other funds holding LLY

Oxbow Advisors's LLY Position: Q3 2026 in Review

Oxbow Advisors opened a new position in Eli Lilly (LLY) in Q3 2026: 201 shares worth $233K. The stake represents 0.02% of the portfolio and ranks #236 among its holdings. This is a return to the name: Oxbow Advisors previously reported a position in LLY as recently as Q2 2025.

Oxbow Advisors first reported a position in LLY in Q2 2017 and has held it in 23 quarters since. The position peaked at $967K in Q3 2024. 4,599 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Oxbow Advisors held 201 shares of Eli Lilly worth $233K as of Q3 2026.
  • Eli Lilly was a new Oxbow Advisors position in Q3 2026.
  • Eli Lilly made up 0.02% of Oxbow Advisors's portfolio in Q3 2026, its #236 holding.
  • Oxbow Advisors first reported a position in Eli Lilly in Q2 2017 and has held it in 23 quarters since.
  • Oxbow Advisors's Eli Lilly position peaked at $967K in Q3 2024.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Oxbow Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.